Claire Langrish

Claire Langrish has extensive experience in the biopharmaceutical industry. Claire is currently serving as the Senior Vice President of Immunology & Biology at Alumis. Prior to this, Claire held various roles at Principia Biopharma, including Vice President and Head of Immunology & Biology. Claire has also worked at Theravance Biopharma US, Inc., Takeda, Roche, and DNAX Research Institute. Throughout their career, Claire has focused on target biology, mode of action, and translational research in immune-mediated diseases. Claire has made significant contributions, such as identifying the role of IL-23 in autoimmunity and discovering Th17 cells, leading to the development of new medicines.

Claire Langrish has a BSc (Hons) ARCS degree in Biochemistry from Imperial College London. Claire also holds a Doctor of Philosophy (Ph.D.) in Immunology from UCL.